• Latrunculin A for Mechanobiology Assays

  2026-08-31

  Use Latrunculin A to separate stiffness sensing from actin-dependent growth-cone remodeling in DRG neuron experiments. This workflow combines rapid, reversible cytoskeleton perturbation with quantitative imaging, making it useful for mechanobiology, migration, and morphology assays.

• Bismuth Subsalicylate in GI and Cell Assays

  2026-08-30

  Bismuth Subsalicylate supports gastrointestinal disorder research while offering a practical platform for studying inflammation pathway modulation and membrane changes. This workflow pairs careful handling of an insoluble bismuth salt with recombinant annexin V assays to separate pathway effects from nonspecific cellular injury.

• DNase I (RNase-free) for Translational RNA Fidelity

  2026-08-29

  A thought-leadership guide to using DNase I (RNase-free) as a data-quality control in RNA extraction, RT-PCR, in vitro transcription, and tumor-microenvironment research. The article connects DNA-removal strategy with mechanistic studies of CAF-derived lactate, ANTXR1 lactylation, cancer stemness, and oxaliplatin resistance while distinguishing established evidence from workflow recommendations.

• T0070907: A Precision PPARγ Antagonist

  2026-08-28

  T0070907 is a covalent, high-affinity PPARγ antagonist for separating receptor-dependent transcription from downstream cellular effects. Use it to interrogate adipogenesis, RXRα/PPARγ pathway activity, macrophage inflammation, and cancer-associated cell-cycle phenotypes with orthogonal controls.

• Indazole/Indole Glucagon Receptor Antagonists

  2026-08-28

  This 2015 Bioorganic & Medicinal Chemistry Letters study introduced indazole- and indole-based glucagon receptor antagonists derived from the MK-0893 concept. Focused SAR optimization produced compounds with strong in vitro activity, favorable rat pharmacokinetics, and oral glucose-lowering activity for GRA 16d in humanized glucagon receptor mouse models.

• How CART–RNA Morphology Shapes Delivery

  2026-08-27

  The reference study shows that low-molar-mass Charge-Altering Releasable Transporters (CARTs) form RNA-driven, disordered bicontinuous nanoparticles rather than simple compact polymer aggregates. By combining cryo-electron microscopy, tomography, and small-angle scattering, the work connects polymer chemistry and RNA cargo identity with internal domain spacing and order, providing structural principles for polymer-based RNA delivery.

• GSK-923295: Rethinking CENP-E in Mitosis

  2026-08-27

  GSK-923295 offers a mechanistically defined route to interrogate CENP-E, chromosome alignment, and mitotic fidelity. By placing this small-molecule CENP-E inhibitor alongside emerging evidence on CTCF-dependent centromere architecture, translational researchers can distinguish motor-driven chromosome congression defects from broader centromere maintenance failures.

• LLY-507: Translating SMYD2 Biology

  2026-08-26

  LLY-507 is a selective SMYD2 inhibitor that helps translational researchers connect substrate-specific lysine methylation with cancer cell phenotypes and fibrosis biology. This article examines its mechanism, assay strategy, evidence boundaries, and product-development relevance while distinguishing biochemical potency from cellular pharmacology and clinical readiness.

• METTL16–SENP3–LTF Axis in HCC Ferroptosis

  2026-08-26

  Wang et al. identify a METTL16–SENP3–LTF signaling axis that protects hepatocellular carcinoma cells from ferroptosis by reducing the labile iron pool. The study connects m6A-dependent RNA regulation with post-translational control of lactotransferrin, providing a mechanistic framework for testing iron availability as a determinant of HCC progression and ferroptosis sensitivity.

• JNJ-10198409: A Time-Aware PDGF Inhibitor

  2026-08-25

  JNJ-10198409 is a potent platelet-derived growth factor receptor inhibitor for dissecting PDGF-BB-driven kinase signaling, proliferation, and angiogenesis. This article connects its receptor-proximal pharmacology with a 2025 RSV study to show why signaling timing, phosphorylation state, and orthogonal assay design matter.

• Drosophila Keap1, Lamin, and Nuclear Architecture

  2026-08-25

  Carlson and colleagues identify a functional interaction between Drosophila Keap1 and the B-type lamin Dm0, connecting xenobiotic-response signaling with nuclear organization. Their genetic and cell-biological evidence suggests that altered dKeap1 activity can redistribute lamin, promote heterochromatin-associated H3K9me2 spreading, and influence developmental viability.

• MACC1–HNRNPH1 Control of IRAK1 Splicing in LUAD

  2026-08-24

  The reference study identifies a mechanism in which MACC1 promotes lung adenocarcinoma progression by partnering with HNRNPH1 to favor the long IRAK1 transcript, IRAK1-L, over IRAK1-S. Its domain-level and RNA-splicing findings connect an oncogenic protein to a specific alternative-splicing event, providing a mechanistic framework for studying MACC1-driven tumor biology and validating isoform-specific molecular assays.

• TG003: A Mechanistic Guide to Clk Assays

  2026-08-24

  TG003 is a Cdc2-like kinase inhibitor that connects kinase activity with alternative splicing and CLK2-associated platinum resistance. This guide focuses on assay design, selectivity limits, and how to interpret splicing and cancer-model data without overstating translational evidence.

• Sunitinib in Reproducible Cell Viability Assays

  2026-08-23

  This scenario-based guide explains how Sunitinib (SKU B1045) can help researchers design interpretable viability, proliferation, apoptosis, and cell-cycle experiments. It covers assay compatibility, stock preparation, data interpretation, and practical vendor-selection criteria for RTK-focused cancer research.

• MEDUSA Reveals Hidden Mechanisms of Drug-Induced Death

  2026-08-22

  Honeywell and colleagues developed MEDUSA, a simulation-assisted framework that separates drug-induced growth inhibition from cell death in functional genomic screens. Applied to DNA damage responses, the method showed that loss of p53 can redirect lethality from apoptosis toward a nonapoptotic, respiration-dependent state, improving interpretation of chemo-genetic data.

8633 records 1/576 page Next 12345 下5页 Last page